세계의 외과용 실란트 시장 예측(2025-2030년)

The Global Surgical Sealants Market is expected to grow from USD 2.019 billion in 2025 to USD 3.202 billion in 2030, at a CAGR of 9.66%.

The global surgical sealants market is experiencing significant growth, driven by the increasing demand for minimally invasive surgeries, which reduce patient recovery time, hospital stays, and associated costs. Surgical sealants, encompassing biologically derived, synthetic, and semi-synthetic forms, are replacing traditional sutures and staples due to their ability to close surgical wounds and control active bleeding effectively during and post-surgery. Unlike sutures, which can be painful and carry infection risks, sealants offer a less invasive and more efficient alternative, enhancing patient outcomes.

A notable advancement in this field is the development of MeTro surgical glue, a highly elastic sealant utilizing elastin protein. This innovative technology, developed by biomedical engineers from the University of Sydney and collaborators in the United States, transforms into a gel upon application, enabling prolonged retention on wounds and promoting rapid healing within 60 seconds. MeTro is particularly designed for challenging surgical closures, such as those involving the lungs, heart, and arteries, where reopening poses significant risks. The technology is set to be commercialized by Elastagen Pty Ltd., marking a pivotal step in advancing surgical care.

Market Segmentation Analysis

By Form

The surgical sealants market is segmented into biological and synthetic categories. Biological sealants, primarily fibrin-based, act as a template for accelerated wound healing but carry a higher risk of disease transmission due to their animal or human-derived origins. In contrast, synthetic sealants, which activate blood clotting cascades to control intraoperative bleeding, are gaining traction and are expected to capture a significant market share due to their safety profile and efficacy.

By Geography

North America dominates the market, driven by the early adoption of advanced technologies and a substantial population seeking surgical care. The region generates the highest revenue, with key players such as Baxter International, CryoLife, C.R. Bard, CSL Behring, Cohera Medical, and Johnson & Johnson leading the industry. Meanwhile, the Asia Pacific region is poised for substantial growth, with a notable compound annual growth rate (CAGR) during the forecast period. This growth is fueled by improving healthcare infrastructure, a rising geriatric population, and an increase in surgical procedures due to road accidents in countries like China and India. These factors are significantly boosting the demand for surgical sealants in the region.

In summary, the surgical sealants market is advancing rapidly, propelled by technological innovations like MeTro glue and the growing preference for minimally invasive procedures. North America remains the revenue leader, while the Asia Pacific region shows strong growth potential due to demographic and infrastructural developments.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Sealants Market Segmentation:

By Form

• Synthetic
• Biological

By Type

• Fibrin Sealants
• Collagen-based Sealants
• Cyanoacrylates
• Albumin and Glutaraldehyde-based Sealants
• Polyethylene Glycol (PEG) Hydrogels
• Others

By Application

• Cardiovascular surgery
• Neurological surgery
• Orthopedic surgery
• General surgery
• Pulmonary surgery
• Cosmetic surgery
• Others

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Geography

• North America
• South America
• Europe
• Middle East and Africa
• Asia Pacific

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SURGICAL SEALANTS MARKET BY FORM

• 5.1. Introduction
• 5.2. Synthetic
• 5.3. Biological

6. GLOBAL SURGICAL SEALANTS MARKET BY TYPE

• 6.1. Introduction
• 6.2. Fibrin Sealants
• 6.3. Collagen-based Sealants
• 6.4. Cyanoacrylates
• 6.5. Albumin and Glutaraldehyde-based Sealants
• 6.6. Polyethylene Glycol (PEG) Hydrogels
• 6.7. Others

7. GLOBAL SURGICAL SEALANTS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Cardiovascular surgery
• 7.3. Neurological surgery
• 7.4. Orthopedic surgery
• 7.5. General surgery
• 7.6. Pulmonary surgery
• 7.7. Cosmetic surgery
• 7.8. Others

8. GLOBAL SURGICAL SEALANTS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Specialty Clinics
• 8.4. Ambulatory Surgical Centers
• 8.5. Others

9. GLOBAL SURGICAL SEALANTS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Form
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Form
  • 9.3.2. By Type
  • 9.3.3. By Application
  • 9.3.4. By End-User
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Form
  • 9.4.2. By Type
  • 9.4.3. By Application
  • 9.4.4. By End-User
  • 9.4.5. By Country
    • 9.4.5.1. United Kingdom
    • 9.4.5.2. Germany
    • 9.4.5.3. France
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Form
  • 9.5.2. By Type
  • 9.5.3. By Application
  • 9.5.4. By End-User
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Form
  • 9.6.2. By Type
  • 9.6.3. By Application
  • 9.6.4. By End-User
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. Japan
    • 9.6.5.3. India
    • 9.6.5.4. South Korea
    • 9.6.5.5. Taiwan
    • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Johnson & Johnson
• 11.2. Baxter International Inc.
• 11.3. Becton, Dickinson and Company
• 11.4. CSL Behring
• 11.5. Artivion Inc.
• 11.6. Integra LifeSciences Holdings Corporation
• 11.7. Medtronic plc
• 11.8. Zimmer Biomet
• 11.9. B. Braun Melsungen AG
• 11.10. Arch Therapeutics, Inc.

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations